Novel methylenedioxy phenolic compounds and their use to treat disease

Details for Australian Patent Application No. 2009279667 (hide)

Owner Invasc Therapeutic, Inc.

Inventors Parthasarathy, Sampath; Rajagopalan, Sanjay; Rajagopal, Desikan

Agent Spruson & Ferguson

Pub. Number AU-A-2009279667

PCT Pub. Number WO2010/017323

Priority 61/086,425 05.08.08 US

Filing date 5 August 2009

Wipo publication date 11 February 2010

International Classifications

C07D 317/64 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/36 (2006.01)

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4178 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/017323 Priority application(s): WO2010/017323

24 March 2011 Alteration of Name

  The name of the applicant has been altered to The Ohio State University Research Foundation; Invasc Therapeutic, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279676-Radioprotectants targeting thrombospondin-1 and CD47

2009279661-Use of mTOR inhibitors to enhance T cell immune responses